We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Dietary Factors Limit Inflammation and Prevent Colon Cancer

By LabMedica International staff writers
Posted on 28 Aug 2018
A team of cancer researchers working with a mouse model has found that a chemical generated during digestion of vegetables such kale, cabbage, and broccoli activates a protein that helps maintain the integrity of the cells lining the gut – preventing chronic inflammation that has been implicated in the development of colon cancer.

The epithelium and immune compartment in the intestine are constantly exposed to a fluctuating external environment. More...
Defective communication between these compartments at this barrier surface underlies susceptibility to infections and chronic inflammation.

In this regard, investigators at the Francis Crick Institute (London, United Kingdom) found that generation of intestinal epithelial cells upon injury through infection or chemical insults was profoundly influenced by the environmental sensor aryl hydrocarbon receptor (AHR). This protein is a member of the family of basic helix-loop-helix transcription factors. AHR binds several exogenous ligands such as natural plant flavonoids, polyphenolics, and indoles, as well as synthetic polycyclic aromatic hydrocarbons and dioxin-like compounds.

The investigators reported in the August 14, 2018, online edition of the journal Immunity that mice receiving a diet rich in indole-3-carbinol (I3C), which is produced during digestion of vegetables of the genus Brassica, were protected from gut inflammation and colon cancer. Specific deletion of Ahr from intestinal epithelial cells resulted in failure to control Citrobacter rodentium infection due to unrestricted intestinal stem cell (ISC) proliferation and impaired differentiation, culminating in transformation into cancer cells. AHR activation by dietary ligands, such as I3C, restored barrier homeostasis, protected the stem cell niche, and prevented tumor formation.

"Seeing the profound effect of diet on gut inflammation and colon cancer was very striking," said senior author Dr. Gitta Stockinger, group leader at the Francis Crick Institute. "We often think of colon cancer as a disease promoted by a Western diet rich in fat and poor in vegetable content, and our results suggest a mechanism behind this observation. Many vegetables produce chemicals that keep AhR stimulated in the gut. We found that AhR-promoting chemicals in the diet can correct defects caused by insufficient AhR stimulation. This can restore epithelial cell differentiation, offering resistance to intestinal infections and preventing colon cancer. These findings are a cause for optimism; while we cannot change the genetic factors that increase our risk of cancer, we can probably mitigate these risks by adopting an appropriate diet with plenty of vegetables."

"A number of epidemiological studies suggested that vegetables may be protective against cancer," said Dr. Stockinger. "However, there is very little literature on which vegetables are the most beneficial or why. Now that we have demonstrated the mechanistic basis for this in mice, we are going to investigate these effects in human cells and people. In the meantime, there is certainly no harm in eating more vegetables!"

Related Links:
Francis Crick Institute


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.